Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-03
2006-10-03
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S310100
Reexamination Certificate
active
07115645
ABSTRACT:
Benzimidazoles of general formula Iand the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation are described.
REFERENCES:
patent: 5344843 (1994-09-01), Guthrie et al.
patent: 5552426 (1996-09-01), Lunn et al.
patent: 4330959 (1995-03-01), None
patent: 0 104 727 (1984-04-01), None
patent: 0 520 200 (1992-12-01), None
patent: 0 528 164 (1993-02-01), None
patent: 0 531 883 (1993-03-01), None
patent: 0694535 (1996-01-01), None
patent: 1561049 (1969-03-01), None
patent: 1174493 (1969-12-01), None
patent: 95/07263 (1995-03-01), None
patent: 97/12613 (1997-04-01), None
patent: 97/33873 (1997-09-01), None
McGeer, P. L., Neurology, 42, 447-449, 1992.
McGeer, P. L., Brain Res. Rev. 21:195-218 (1992).
Chen et. al., Neurobiol. Aging (1996).
Thomas et. al., “Minocycline: Neuroprotective Mechanisms in Parkinson's Disease”, Current Pharmaceutical Design, 2004, 67 686.
Thomas et. al., “Minocycline: Neuroprotective Mechanisms in Parkinson's Disease”, Current Pharmaceutical Design, 2004, 679-686.
Hcaplus 2005:20310, Lott et. al.
Hcaplus 125:300996.
Hcaplus 124:289536, Burns et. al.
Hcaplus 122:236400.
Hcaplus 132:206042.
Halliday et al. Clinical and Experimental Pharmacology and Physiology, Jan. 2000, vol. 27 (1-2), p. 1-8. *Internet printout attached.
Halfbrodt Wolfgang
Kuhnke Joachim
Moenning Ursula
Berlex Inc.
Hermenau Ronald S.
Larson Jacqueline S.
Nolan Jason M.
Saeed Kamal A.
LandOfFree
1,2 diarylbenzimidazoles and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2 diarylbenzimidazoles and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2 diarylbenzimidazoles and their pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3685859